MyMedR
Advanced
  • Browse
  • Help
  • Login
Advanced

Tuberculosis and leprosy: potential novel drugs and vaccines against Mycobacterium. A Symposium held at Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia, July 3-5, 2002. Proceedings

Tuberculosis (Edinb), 2004;84(1-2):1-130.
PMID: 14670339

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
  • Antitubercular Agents/therapeutic use*
  • Bacterial Vaccines
  • Humans
  • Leprostatic Agents/therapeutic use*
  • Leprosy/therapy*
  • Mycobacterium/immunology
  • Tuberculosis/therapy*
  • Tuberculosis Vaccines*
Similar publications
  • Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance
  • Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review
  • Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives
  • Current prospects of synthetic curcumin analogs and chalcone derivatives against mycobacterium tuberculosis
  • Delays in seeking treatment for symptomatic tuberculosis in Sabah, East Malaysia: factors for patient delay
  • Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia
  • Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
  • Tuberculosis Treated by Multiple Drugs: An Overview
  • Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy
  • Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges
  • Related publications on PubMed
Copyright © 2026 MyMedR. Developed by Rakit.

* MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.